Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | MEN1 | O00255 | 1/20 | 0.43 |
| ▸ | SLC28A3 | Q9HAS3 | 3/20 | 0.43 |
| ▸ | SLC5A2 | P31639 | 3/20 | 0.42 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | TYR | P14679 | 1/20 | 0.41 |
| ▸ | CA12 | O43570 | 3/20 | 0.41 |
| ▸ | CA9 | Q16790 | 3/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14514190 | 1.00 | ALDH1A1 (0.45) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL14514178 | 0.88 | ALDH1A1 (0.46) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL14514189 | 0.88 | ALDH1A1 (0.46) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL14514181 | 0.82 | SLC5A1 (0.33) | ALDH1A1KMT2AMEN1SLC5A2 | |
| SCHEMBL14514179 | 0.76 | ALDH1A1 (0.45) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL14514177 | 0.75 | ALDH1A1 (0.49) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL14514180 | 0.74 | ALDH1A1 (0.43) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL14539205 | 0.74 | ALDH1A1 (0.43) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL26601099 | 0.73 | ALDH1A1 (0.47) | ALDH1A1POLBKMT2AMEN1SLC28A3 | |
| SCHEMBL22882206 | 0.73 | ALDH1A1 (0.49) | ALDH1A1POLBKMT2AMEN1SLC28A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070111952-A1 | Glycosylated triketide delta lactones | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2007-05-17 | — | — | US | disclosed |
| US-20070111952-A1 | Glycosylated triketide delta lactones | UNIVERSITE CATHOLIQUE DE LOUVAIN (BE) | 2007-05-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070111952-A1 | Glycosylated triketide delta lactones | AGL, AKR1C3, AKR1C4 | ALDH1A1 416/4885POLB 4605/4885KMT2A 2411/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.